Inhibition of ERK1/2 or CRMP2 Disrupts Alcohol Memory Reconsolidation and Prevents Relapse in Rats

Int J Mol Sci. 2024 May 17;25(10):5478. doi: 10.3390/ijms25105478.

Abstract

Relapse to alcohol abuse, often caused by cue-induced alcohol craving, is a major challenge in alcohol addiction treatment. Therefore, disrupting the cue-alcohol memories can suppress relapse. Upon retrieval, memories transiently destabilize before they reconsolidate in a process that requires protein synthesis. Evidence suggests that the mammalian target of rapamycin complex 1 (mTORC1), governing the translation of a subset of dendritic proteins, is crucial for memory reconsolidation. Here, we explored the involvement of two regulatory pathways of mTORC1, phosphoinositide 3-kinase (PI3K)-AKT and extracellular regulated kinase 1/2 (ERK1/2), in the reconsolidation process in a rat (Wistar) model of alcohol self-administration. We found that retrieval of alcohol memories using an odor-taste cue increased ERK1/2 activation in the amygdala, while the PI3K-AKT pathway remained unaffected. Importantly, ERK1/2 inhibition after alcohol memory retrieval impaired alcohol-memory reconsolidation and led to long-lasting relapse suppression. Attenuation of relapse was also induced by post-retrieval administration of lacosamide, an inhibitor of collapsin response mediator protein-2 (CRMP2)-a translational product of mTORC1. Together, our findings indicate the crucial role of ERK1/2 and CRMP2 in the reconsolidation of alcohol memories, with their inhibition as potential treatment targets for relapse prevention.

Keywords: CRMP2; ERK1/2; addiction; alcohol; memory reconsolidation; signaling.

MeSH terms

  • Alcoholism* / drug therapy
  • Alcoholism* / metabolism
  • Amygdala / drug effects
  • Amygdala / metabolism
  • Animals
  • Ethanol
  • Intercellular Signaling Peptides and Proteins* / metabolism
  • MAP Kinase Signaling System / drug effects
  • Male
  • Mechanistic Target of Rapamycin Complex 1 / metabolism
  • Memory / drug effects
  • Memory Consolidation* / drug effects
  • Mitogen-Activated Protein Kinase 1* / metabolism
  • Mitogen-Activated Protein Kinase 3* / metabolism
  • Nerve Tissue Proteins* / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Rats
  • Rats, Wistar
  • Recurrence
  • Self Administration

Substances

  • collapsin response mediator protein-2
  • Ethanol
  • Intercellular Signaling Peptides and Proteins
  • Mechanistic Target of Rapamycin Complex 1
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Nerve Tissue Proteins
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt